Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission We ...
Serum Proteomic Fingerprinting Discriminates Between Clinical Stages and Predicts Disease Progression in Melanoma Patients Single-arm phase II trials may not be appropriate for testing cytostatic ...
Read the section on Blocking Designs (pages 185-190) in Julian Faraway's Practical Regression and ANOVA using R (2002). This treatment of the topic is very concise and to the point, and gives the R ...
• Randomly assigning patients in a clinical quality registry combines the features of a prospective randomized trial with a large-scale clinical registry • Registry-based trials are less selective and ...
Data from studies in nonhuman primates suggest that the triple monoclonal antibody cocktail ZMapp is a promising immune-based treatment for Ebola virus disease (EVD). A total of 72 patients were ...
You can use the PLAN procedure to design a completely randomized design. Suppose you have 12 experimental units, and want to assign one of two treatments to each unit. Use a DATA step to store the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results